Humacyte (HUMA) Cash from Operations (2020 - 2026)
Humacyte (HUMA) reported Cash from Operations of 25104000.0 for Q1 2026, up 12.22% year-over-year from 22369591.23 in Q1 2025, and up 3.75% quarter-over-quarter from 26082000.0 in Q4 2025.
Humacyte (HUMA) Cash from Operations (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Cash from Operations data on file, last reported at 25104000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 25104000.0, up 12.22% year-over-year; the trailing twelve-month figure through Mar 2026 was 101504000.0 (down 2.17% YoY), and the FY2025 annual result was 105000000.0, down 7.03% from the prior year.
- Cash from Operations improved to 25104000.0 in Q1 2026 per HUMA's latest filing, from 26082000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 13100000.0 in Q3 2023 and troughed at 28600000.0 in Q1 2025.
- A 5-year average of 21919882.35 and a median of 22559000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 45.09% in 2022, then sank 74.86% in 2024.
- A 5-year view of Cash from Operations shows it stood at 18959000.0 in 2022, then fell by 0.24% to 19005000.0 in 2023, then tumbled by 39.73% to 26555000.0 in 2024, then grew by 1.78% to 26082000.0 in 2025, then climbed by 3.75% to 25104000.0 in 2026.
- Business Quant data shows HUMA's Cash from Operations at 25104000.0 in Q1 2026, 26082000.0 in Q4 2025, and 23904000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -25.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.10 Mn |
| Mar 31, 2026 | -25.10 Mn |
| Dec 31, 2025 | -26.08 Mn |
| Dec 31, 2025 | -26.08 Mn |
| Sep 30, 2025 | -23.90 Mn |
| Sep 30, 2025 | -23.90 Mn |
| Jun 30, 2025 | -26.41 Mn |
| Jun 30, 2025 | -26.41 Mn |
| Mar 31, 2025 | -28.60 Mn |
| Mar 31, 2025 | -28.60 Mn |
| Dec 31, 2024 | -26.56 Mn |
| Dec 31, 2024 | -26.56 Mn |
| Sep 30, 2024 | -22.91 Mn |
| Sep 30, 2024 | -22.91 Mn |
| Jun 30, 2024 | -21.29 Mn |
| Jun 30, 2024 | -21.29 Mn |
| Mar 31, 2024 | -27.35 Mn |
| Mar 31, 2024 | -27.35 Mn |
| Dec 31, 2023 | -19.01 Mn |
| Dec 31, 2023 | -19.01 Mn |